The Woodlands, TX1 Active Studies

Myeloproliferative Neoplasms Clinical Trials in The Woodlands, TX

Find 1 actively recruiting myeloproliferative neoplasms clinical trials in The Woodlands, TX. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
65
Enrolling

Recruiting Myeloproliferative Neoplasms Studies in The Woodlands

About Myeloproliferative Neoplasms Clinical Trials in The Woodlands

Myeloproliferative neoplasms (MPNs) are blood cancers in which the bone marrow overproduces red blood cells, platelets, or white blood cells. Types include polycythemia vera, essential thrombocythemia, and myelofibrosis. Treatment depends on the specific type and risk factors.

There are currently 1 myeloproliferative neoplasms clinical trials recruiting participants in The Woodlands, TX. These studies are seeking a combined 65 participants. Research is being sponsored by Silence Therapeutics plc. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myeloproliferative Neoplasms Clinical Trials in The Woodlands — FAQ

Are there myeloproliferative neoplasms clinical trials in The Woodlands?

Yes, there are 1 myeloproliferative neoplasms clinical trials currently recruiting in The Woodlands, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in The Woodlands?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the The Woodlands research site will contact you about next steps.

Are clinical trials in The Woodlands free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many The Woodlands studies also compensate for your time and travel.

What myeloproliferative neoplasms treatments are being tested?

The 1 active trials in The Woodlands are testing new therapies including novel drugs, biologics, and treatment approaches for myeloproliferative neoplasms.

Data updated March 2, 2026 from ClinicalTrials.gov